Brain Cancer Clinical Trials

24 trials recruiting in Canada.

Cancer

Recruiting Drug Device Behavioral Older adults Healthy volunteers

2 trials

Only a few results?

Someone at Concord can look with you.

Comparing Blood Brain Barrier Opening with Pembrolizumab for brain tumor

Explore this study →

There are 2 groups in this study. Group A receives one or more of: Blood Brain Barrier Opening - Oncology, Pembrolizumab, Atezolizumab, Cemiplimab, Nivolumab and Iptilimumab. Group B, the comparison group, receives one or more of: Pembrolizumab, Atezolizumab, Cemiplimab, Nivolumab and Iptilimumab.

One site, in Toronto

Phase 3
2 groups
One site, in Toronto
Recruiting

Official title: Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets

Brain Tumor · InSightec

Testing Optune® device with Temozolomide against a placebo for glioblastoma

Explore this study →

There are 2 groups in this study. Group A receives one or more of: Optune® device, Temozolomide and Pembrolizumab. Group B, the placebo group, receives one or more of: Optune® device, Temozolomide and Placebo.

Sites in Montreal, Edmonton and 4 more cities

Phase 3
2 groups
Sites in Edmonton, Hamilton and 4 more cities
Recruiting

Official title: EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma

Glioblastoma · NovoCure GmbH

Looking for the closest fit?

Get matched →

Ask someone to look with you

Whether or not the results above are what you were looking for, someone at Concord can search with you.

Get notified when a matching trial opens

We'll watch for Brain Cancer trials near you.

← Back to all conditions

Concord provides information support only. Trial listings come from public registries; eligibility is always determined by the trial site and your care team.